Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
出版年份 2013 全文链接
标题
Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 108, Issue 4, Pages 748-754
出版商
Springer Nature
发表日期
2013-01-30
DOI
10.1038/bjc.2013.21
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
- (2012) A Vilas-Zornoza et al. LEUKEMIA
- Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
- (2012) Larry H. Thompson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Adamantanyl-Histone Deacetylase Inhibitor H6CAHA Exhibits Favorable Pharmacokinetics and Augments Prostate Cancer Radiation Sensitivity
- (2011) Zacharoula Konsoula et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
- (2011) Shweta Kotian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic
- (2011) Jacob E. Shabason et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
- (2011) Åse Bratland et al. Radiation Oncology
- Targeting abnormal DNA double strand break repair in cancer
- (2010) Feyruz V. Rassool et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mre11–Rad50–Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks
- (2010) Gareth J. Williams et al. DNA REPAIR
- The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax
- (2010) Aaron A. Goodarzi et al. DNA REPAIR
- Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition
- (2010) Claudia Blattmann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
- (2010) Kyle M Miller et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
- (2010) Sushant K. Kachhap et al. PLoS One
- HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
- (2010) O. Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
- (2010) J.- H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
- (2009) Xufeng Chen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Successful Treatment of Anaplastic Thyroid Carcinoma with a Combination of Oral Valproic Acid, Chemotherapy, Radiation and Surgery
- (2009) Hitoshi NOGUCHI et al. ENDOCRINE JOURNAL
- Inhibition of vimentin or 1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo
- (2009) X. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
- (2008) L Nolan et al. BRITISH JOURNAL OF CANCER
- Acute Toxicity in a Phase II Clinical Trial of Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with Glioblastoma Multiforme
- (2008) M. Kamrava et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now